Interleukin (IL)-1 Blockade in Acute Heart Failure (Anakinra ADHF)

NCT01936844 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Heart Failure

Interventions

DRUG: Anakinra (high dose)
DRUG: Anakinra (standard dose)
DRUG: Placebo
DRUG: Placebo

Sponsor

Virginia Commonwealth University

Collaborators

[object Object]